Abstract
Hemophilia A, von Willebrand's disease and uremia prolong the bleeding time in affected children. Management of hemorrhage is difficult in these patients, and often requires multiple therapeutic modalities. Desmopressin, a synthetic analog of arginine vasopressin (DDAVP), decreases the bleeding time in patients with these disorders. We describe a case of a child with uremia and spontaneous epistaxis originating from the adenoid. Bleeding was controlled with administration of DDAVP and other measures. DDAVP is effective for the rapid, temporary correction of prolonged bleeding time associated with hemophilia A, von Willebrand's disease or uremia. The use of DDAVP avoids the risks associated with blood component transfusion. DDAVP may be used as a single hemostatic agent in minor surgical procedures, or in combination with other therapeutic modalities in major surgical procedures.
References
Apr 23, 1977·Lancet·P M MannucciA Capitanio
Oct 20, 1978·JAMA : the Journal of the American Medical Association·M E Kosman
Aug 1, 1985·Annals of Internal Medicine·D W Richardson, A G Robinson
May 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S J Jubelirer
Jul 1, 1985·Annals of Internal Medicine·B de la FuenteL W Hoyer
Dec 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·E GottiG Remuzzi
May 26, 1984·Lancet·N L KobrinskyM L Schroeder
Jan 6, 1983·The New England Journal of Medicine·A C Carvalho
Jan 6, 1983·The New England Journal of Medicine·P M MannucciT S Zimmerman
Feb 1, 1983·The Journal of Pediatrics·A I Warrier, J M Lusher
Oct 6, 1983·The New England Journal of Medicine·L HolmbergE Sjörin
Jun 1, 1980·Thrombosis Research·D L DewaldR E Smith
Jul 1, 1980·British Journal of Haematology·C A LudlamA L Bloom
Dec 4, 1980·The New England Journal of Medicine·P A JansonD Deykin
Feb 1, 1981·British Journal of Haematology·P M MannucciB S Donovan